(HYDB) iShares Edge High Yield - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46435G2509 • High Yield Bond
HYDB: Bonds, Corporate Debt, High Yield Bonds
The iShares Edge High Yield Defensive Bond ETF (HYDB) is a fixed-income ETF designed to provide exposure to high-yield bonds with a defensive twist. It invests at least 80% of its assets in the component securities of its underlying index, and at least 90% in fixed-income securities of the types included in that index. This structure is intended to align the fund closely with the performance of its benchmark while maintaining a focus on higher-yield debt instruments.
With an AUM of $1.226 billion, HYDB is a sizeable fund in the high-yield bond ETF category. It trades on the BATS exchange under the ticker symbol HYDB. The fund is structured to appeal to investors seeking income from higher-yielding, lower-rated corporate bonds while incorporating defensive characteristics to mitigate potential downside risks.
As a high-yield bond ETF, HYDB is designed for investors looking to tap into the returns of below-investment-grade debt securities. These bonds typically offer higher yields to compensate for the increased credit risk. The funds defensive approach may make it more attractive to risk-averse investors within the high-yield category, as it seeks to balance income generation with a focus on stability.
Its important for investors and fund managers to note that high-yield bond funds like HYDB are sensitive to changes in interest rates and credit market conditions. While they can provide attractive yields, they also carry higher default risk compared to investment-grade bonds. The funds performance will depend on the ability of its managers to select and monitor the underlying securities effectively.
For those evaluating HYDB, it’s crucial to consider the current economic cycle. High-yield bonds often perform well in a late-cycle environment where defaults remain low, but they can be more volatile during periods of economic uncertainty or rising interest rates. As with any ETF, understanding the underlying index, expense structure, and the issuers track record is essential for making an informed decision.
Additional Sources for HYDB ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HYDB ETF Overview
Market Cap in USD | 1,535m |
Category | High Yield Bond |
TER | 0.35% |
IPO / Inception | 2017-07-11 |
HYDB ETF Ratings
Growth 5y | 65.9% |
Fundamental | - |
Dividend | 71.8% |
Rel. Strength Industry | 8.49 |
Analysts | - |
Fair Price Momentum | 48.61 USD |
Fair Price DCF | - |
HYDB Dividends
Dividend Yield 12m | 6.61% |
Yield on Cost 5y | 9.64% |
Annual Growth 5y | 1.87% |
Payout Consistency | 97.5% |
HYDB Growth Ratios
Growth Correlation 3m | 81.6% |
Growth Correlation 12m | 97.3% |
Growth Correlation 5y | 67.2% |
CAGR 5y | 8.07% |
CAGR/Max DD 5y | 0.57 |
Sharpe Ratio 12m | 1.49 |
Alpha | 3.97 |
Beta | 0.22 |
Volatility | 4.62% |
Current Volume | 2679k |
Average Volume 20d | 240.4k |
As of March 15, 2025, the stock is trading at USD 47.03 with a total of 2,678,967 shares traded.
Over the past week, the price has changed by -0.84%, over one month by -0.52%, over three months by +0.51% and over the past year by +9.58%.
Yes. Based on ValueRay Analyses, iShares Edge High Yield (BATS:HYDB) is currently (March 2025) a good stock to buy. It has a ValueRay Growth Rating of 65.90 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HYDB as of March 2025 is 48.61. This means that HYDB is currently overvalued and has a potential downside of 3.36%.
iShares Edge High Yield has no consensus analysts rating.
According to ValueRays Forecast Model, HYDB iShares Edge High Yield will be worth about 52.9 in March 2026. The stock is currently trading at 47.03. This means that the stock has a potential upside of +12.48%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 52.9 | 12.5% |